Skip navigation


Company: Merck & Co Inc

Merck & Co Inc : [MRK  Loading...      ()   ]
Thursday, 24 May 2012 | Source: Reuters
NEW YORK (Reuters) - Another showdown between Republicans in Congress and President Barack Obama over debt could be in the making, and some investors are already taking steps to prepare for it.
Thursday, 24 May 2012 | Source: Reuters
LOS ANGELES (Reuters) - Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama's healthcare overhaul, could come under more pressure if the U.S. Supreme Court strikes down part or all of the 2010 law.
Tuesday, 22 May 2012 | Source: The Associated Press
Merck & Co. CEO Kenneth Frazier told company shareholders on Tuesday that 2012 and 2013 will be difficult years, but he's confident the company can weather them.
Friday, 18 May 2012 | Source: Reuters
(Reuters) - All baby boomers should be tested at least once for the liver-destroying hepatitis C virus, according to proposed guidelines from U.S. health officials released on Friday.
Friday, 18 May 2012 | Source: Reuters
(Reuters) - All baby boomers should be tested at least once for the liver-destroying hepatitis C virus, according to proposed guidelines from U.S. health officials released on Friday.
Thursday, 10 May 2012 | Source: The Associated Press
Shares of Amag Pharmaceuticals Inc. sank Thursday, a day after the anemia drug maker said it is no longer considering selling itself.
Wednesday, 9 May 2012 | Source: Reuters
FRANKFURT (Reuters) - Germany's Merck KGaA said on Wednesday that Erbitux, one of its most important drugs, failed to help colon cancer patients after surgery in a late stage trial.
Monday, 7 May 2012 | Source: The Associated Press
A second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies.
Monday, 7 May 2012 | Source: Reuters
NEW YORK (Reuters) - More than 100 years after researchers first explored the potential to harness the body's immune system to fight cancer, the field's leading doctors see the concept finally proving itself on a large scale in the next year or two.
Tuesday, 1 May 2012 | Source: Reuters
ACCRA (Reuters) - In Emanuel Adu's language, Twi, people call the skin cancer that is invading his cheek and nose "sasabro". It means a disease that eats away at you.
Tuesday, 1 May 2012 | Source: Reuters
ACCRA (Reuters) - In Emanuel Adu's language, Twi, people call the skin cancer that is invading his cheek and nose "sasabro". It means a disease that eats away at you.
Tuesday, 1 May 2012 | Source: Reuters
ACCRA (Reuters) - In Emanuel Adu's language, Twi, people call the skin cancer that is invading his cheek and nose "sasabro". It means a disease that eats away at you.
Monday, 30 Apr 2012 | Posted By:  | Source: CNBC.com
Stocks ended lower in thin trading Monday, with the S&P and the Nasdaq posting a loss for the month of April, following a handful of mixed economic reports in addition to news that Spain slipped into a recession.
Saturday, 28 Apr 2012 | Source: Reuters
(Reuters) - A U.S. court on Friday ruled that the patent on Merck & Co's <MRK.N> cholesterol fighter Zetia and a related drug Vytorin was valid and issued an injunction blocking approval of a generic version by Mylan Inc <MYL.O> until the patent expires.
Friday, 27 Apr 2012 | Source: Reuters
(Reuters) - A U.S. court on Friday ruled that the patent on Merck & Co's <MRK.N> cholesterol fighter Zetia and a related drug Vytorin was valid and issued an injunction blocking approval of a generic version by Mylan Inc <MYL.O> until the patent expires.
Next
Posts |  COMPANY : Merck & Co Inc
22 May 2012
The SPDR Health Care Select Sector exchange-traded fund is less than a sneeze from its recent highs, and some bulls are looking for it to pop.... Read More
10 May 2012
Posted By:Richard SaintvilusCNBC Stock Blog
Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years... Read More
27 Apr 2012
Take a look at some of Friday's morning movers.... Read More
22 Apr 2012
A crush of earnings news in the coming week will compete head on with new data on the health of the U.S... Read More
10 Apr 2012
Posted By:Frank ByrtCNBC Stock Blog
TheStreet.com details the 10 most popular high-yielding dividend stocks among Morningstar's Ultimate Stock-Pickers funds, listed in inverse order of highest yield.... Read More
VIDEO | COMPANIES : Merck & Co Inc
CNBC's Kayla Tausche breaks down the numbers in a recent CNBC-AP poll which shows investors are leery about Facebook's m...


Current DateTime: 02:09:10 24 May 2012
LinksList Documentid: 23188555



Current DateTime: 02:09:10 24 May 2012
LinksList Documentid: 23188557

Current DateTime: 05:24:27 25 May 2012
LinksList Documentid: 29778428

Current DateTime: 02:09:06 24 May 2012
LinksList Documentid: 29779196

Current DateTime: 12:59:34 25 May 2012
LinksList Documentid: 29779197

Current DateTime: 08:53:35 25 May 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters